ArticleInternational journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases2020

Reducing mortality and morbidity in patients with severe COVID-19 disease by advancing ongoing trials of Mesenchymal Stromal (stem) Cell (MSC) therapy - Achieving global consensus and visibility for cellular host-directed therapies.

Alimuddin Zumla et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.